MedPath

Internet-based Treatment of Stress and Anxiety in Myocardial Infarction With Non-obstructive Coronary Arteries

Not Applicable
Recruiting
Conditions
Myocardial Infarction
Interventions
Behavioral: Internet-based CBT intervention
Registration Number
NCT04178434
Lead Sponsor
Per Tornvall
Brief Summary

Patient with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome often have high levels of stress and anxiety. At present there are no treatment alternatives in this group of patients. Previously, cognitive behavioral therapy (CBT), primarily aiming at relieving stress, has been shown to decrease morbidity in patient with myocardial infarction with obstructive coronary arteries. The present open randomized study aims to decrease stress and anxiety in patients with myocardial infarction with non-obstructive coronary arteries and takotsubo syndrome by an internet-based CBT focusing on stress and anxiety.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
  • age 35-80 years
  • admission-ECG with sinus rhythm
  • PSS-14 ≥ 25 and/or HADS-A ≥ 8 during admission
  • reading and writing proficiency in Swedish
  • computer/Internet access and literacy
Exclusion Criteria
  • strong clinical suspicion of myocarditis
  • spontaneous coronary artery dissection
  • acute pulmonary embolism
  • acute myocardial infarction type 2
  • cardiomyopathy other than takotsubo syndrome
  • a previous myocardial infarction due to CAD
  • expected poor compliance to behavioural therapy
  • not likely to survive > one year due to for example cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Internet-based CBT interventionInternet-based CBT interventionA nine step internet-based intervention with focus on stress and anxiety
Primary Outcome Measures
NameTimeMethod
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)12-14 weeks after the acute event

Normalisation of HADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)

Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)12-14 weeks after the acute event

Normalisation of PSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)

Secondary Outcome Measures
NameTimeMethod
Self-rated anxiety as determined by Hospital Anxiety and Depression Scale (HADS)10, 20 and 50 weeks after randomisation

HADS-A (\<8 on a scale 0-21 with high numbers indicating increased anxiety)

Cortisol in hair10 weeks after randomisation

Hair cortisol will be determined by RIA-technique in pg/mg

Self-rated post-traumatic symptoms determined by Impact of Event Scale-6 (IES-6)10, 20 and 50 weeks after randomisation

IES-6: 0-30 with high numbers indicating increased post-traumatic symptoms

Physiological recovery after stress determined by salivary cortisol10 weeks after randomisation

Salivary cortisol will be determined by RIA-technique in pg/mg

Self-rated cardiac anxiety determined by Cardiac Anxiety Questionnaire (CAQ)10, 20 and 50 weeks after randomisation

CAQ: 0-72 with high numbers indicating increased cardiac anxiety

Sick leave10, 20 and 50 weeks after randomisation

Self-reported total number of days

Self-rated quality-of-life determined by Research ANd Development-36 (RAND-36)10, 20 and 50 weeks after randomisation

RAND-36: 0-100 with high numbers indicating better quality-of-life

Health-care visits10, 20 and 50 weeks after randomisation

Self-reported total number of visits

Physiological recovery after stress determined by Heart Rate Variability (HRV)10 weeks after randomisation

HRV will be measured by time and frequency domains and by non-linear methods

Self-rated stress as determined by Perceived Stress Scale 14 (PSS-14)10, 20 and 50 weeks after randomisation

PSS-14 (\<25 on a scale 0-56 with high numbers indicating increased stress)

Trial Locations

Locations (1)

Södersjukhuset

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath